Back
Celldex Therapeutics Stock Predictions
Do you own any of the "SELL" rated stocks on this list?
Go here now to get free instant access to all 20 stocks to sell.
Sell
37
CLDX
Celldex Therapeutics
Last Price:
32.87
Seasonality Move:
1.08%
7 Day Trial
ALL ACCESS PASS
$
7
Why Over 21,997 Investors Are Flocking to This Opportunity
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Celldex Therapeutics Stock Forecast
- Over the next 52 weeks, Celldex Therapeutics has on average historically risen by 37.1% based on the past 38 years of stock performance.
- Celldex Therapeutics has risen higher in 13 of those 38 years over the subsequent 52-week period, corresponding to a historical accuracy of 34.21%
-
Is Celldex Therapeutics Stock Undervalued?
The current Celldex Therapeutics [CLDX] share price is $36.02. The Score for CLDX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal. - CLDX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Celldex Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Celldex Therapeutics has on average historically risen by 37.1% based on the past 38 years of stock performance.
Celldex Therapeutics Stock Rating
Sell
37
Celldex Therapeutics (CLDX)
is a Sell
Is Celldex Therapeutics overpriced?
- Celldex Therapeutics has risen higher in 13 of those 38 years over the subsequent 52-week period, corresponding to a historical accuracy of 34.21%
Celldex Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
celldex.com
52-Week Data
52-Week High:
53.18
52-Week Low:
22.11
Prediction Charts
Market Cap:
2.39B
Price in USD:
36.02
Volume:
12.32M
Beta:
1.80
Technical Analysis
SMA50:
38.47
SMA100:
37.79
SMA200:
38.87
52-Wk Change:
39.4%
Stock Predictions
-
Is Celldex Therapeutics stock public?
Yes, Celldex Therapeutics is a publicly traded company. -
What is the Celldex Therapeutics stock quote today?
The Celldex Therapeutics stock price is 36.02 USD today. -
How to buy Celldex Therapeutics stock online?
You can buy Celldex Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Sep-6 | 43.80 | 43.76 | 44.13 | 42.78 |
| Sep-9 | 44.00 | 42.28 | 45.15 | 41.71 |
| Sep-10 | 42.55 | 42.04 | 43.16 | 41.74 |
| Sep-11 | 41.79 | 41.64 | 42.36 | 41.22 |
| Sep-12 | 41.68 | 41.77 | 42.33 | 41.36 |
| Sep-13 | 42.16 | 44.16 | 44.28 | 41.97 |
| Sep-16 | 44.24 | 42.86 | 44.53 | 42.75 |
| Sep-17 | 43.34 | 41.24 | 44.87 | 41.11 |
| Sep-18 | 41.50 | 41.85 | 43.19 | 41.50 |
| Sep-19 | 42.89 | 41.16 | 43.02 | 40.82 |
| Sep-20 | 41.13 | 41.24 | 41.88 | 40.45 |
| Sep-23 | 41.47 | 40.17 | 42.12 | 40.15 |
| Sep-24 | 40.20 | 40.98 | 41.51 | 39.60 |
| Sep-25 | 40.84 | 36.02 | 47.00 | 28.51 |
Celldex Therapeutics Earnings
Celldex Therapeutics Earnings Report: Per Share Celldex Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Celldex Therapeutics Forecast Revenue Growth
Celldex Therapeutics Stock Analysis: Historical quarterly revenues per share for Celldex Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.18 per share, an increase this year of $0.19 per share, and a decrease next year of $0.66 per share.
* Celldex Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.